骨转移：肺癌与骨相互作用的时间及方式。
Bone metastases: When and how lung cancer interacts with bone.
作者信息
Roato Ilaria
机构信息
Ilaria Roato, CeRMS, AO Città della Salute e della Scienza di Torino, Department of Medical Science, University of Turin, 10126 Torino, Italy.
出版信息
World J Clin Oncol. 2014 May 10;5(2):149-55. doi: 10.5306/wjco.v5.i2.149.
Abstract
BONE METASTASIS IS A COMMON AND DEBILITATING CONSEQUENCE OF LUNG CANCER
30%-40% of patients with non-small cell lung cancer develop bone metastases during the course of their disease. Lung cancer cells find a favorable soil in the bone microenvironment due to factors released by the bone matrix, the immune system cells, and the same cancer cells. Many aspects of the cross-talk among lung tumor cells, the immune system, and bone cells are not clear, but this review aims to summarize the recent findings in this field, with particular attention to studies conducted to identify biomarkers for early detection of lung cancer bone metastases.
摘要
骨转移是肺癌常见且使人虚弱的后果
30%-40%的非小细胞肺癌患者在病程中会发生骨转移。由于骨基质、免疫系统细胞以及癌细胞自身释放的因子，肺癌细胞在骨微环境中找到了适宜的土壤。肺肿瘤细胞、免疫系统和骨细胞之间相互作用的许多方面尚不清楚，但本综述旨在总结该领域的最新研究结果，尤其关注为识别肺癌骨转移早期检测生物标志物而开展的研究。
相似文献
1
Bone metastases: When and how lung cancer interacts with bone.骨转移：肺癌与骨相互作用的时间及方式。
World J Clin Oncol. 2014 May 10;5(2):149-55. doi: 10.5306/wjco.v5.i2.149.
2
Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.粒细胞免疫浸润对于乳腺癌肝转移的有效形成至关重要。
Breast Cancer Res. 2015 Mar 27;17(1):45. doi: 10.1186/s13058-015-0558-3.
3
Molecular mechanisms of tumor-bone interactions in osteolytic metastases.溶骨性转移中肿瘤与骨相互作用的分子机制
Crit Rev Eukaryot Gene Expr. 2000;10(2):159-78.
4
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
5
Targeting the Metastatic Bone Microenvironment by MicroRNAs.通过微小RNA靶向转移骨微环境
Front Endocrinol (Lausanne). 2018 Apr 27;9:202. doi: 10.3389/fendo.2018.00202. eCollection 2018.
6
Increased Risk of Lung Metastases in Patients with Giant Cell Bone Tumors: A Systematic Review.骨巨细胞瘤患者肺转移风险增加：一项系统评价。
Adv Exp Med Biol. 2019;1176:1-17. doi: 10.1007/5584_2019_372.
7
The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer.非小细胞肺癌脑转移中的免疫微环境
Front Oncol. 2021 Jul 14;11:698844. doi: 10.3389/fonc.2021.698844. eCollection 2021.
8
Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?乳腺癌、肺癌和前列腺癌的性别差异与骨转移：骨归巢性癌症是否更倾向于女性化骨髓？
Front Oncol. 2017 Aug 7;7:163. doi: 10.3389/fonc.2017.00163. eCollection 2017.
9
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.非小细胞肺癌脑转移患者的免疫治疗。了解脑肿瘤微环境并剖析临床免疫检查点阻断治疗的结果。
Cancer Treat Rev. 2020 Sep;89:102067. doi: 10.1016/j.ctrv.2020.102067. Epub 2020 Jul 7.
10
Markers of bone turnover in patients with lung cancer.肺癌患者的骨转换标志物
J Natl Med Assoc. 2008 Apr;100(4):425-8. doi: 10.1016/s0027-9684(15)31276-1.
引用本文的文献
1
Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer.免疫检查点抑制剂治疗对非小细胞肺癌骨转移的疗效。
Front Immunol. 2024 Jun 18;15:1379056. doi: 10.3389/fimmu.2024.1379056. eCollection 2024.
2
Rare Manifestation of Pancreaticobiliary Cancer With Extrahepatic Lesions.伴有肝外病变的胰胆管癌罕见表现
Cureus. 2023 Aug 10;15(8):e43276. doi: 10.7759/cureus.43276. eCollection 2023 Aug.
3
Non-small Cell Lung Carcinoma With Metastases to Various Levels of Vertebra: A Case Report and Literature Review.非小细胞肺癌伴不同椎体水平转移：一例报告及文献复习
Cureus. 2023 Apr 19;15(4):e37851. doi: 10.7759/cureus.37851. eCollection 2023 Apr.
4
Lung Cancer With Vertebral Metastases Presenting as Low Back Pain in the Chiropractic Office: A Case Report.脊椎按摩诊所中以腰痛为表现的肺癌伴椎体转移：一例报告
Cureus. 2023 Feb 9;15(2):e34821. doi: 10.7759/cureus.34821. eCollection 2023 Feb.
5
Risk factor analysis of bone metastasis in patients with non-small cell lung cancer.非小细胞肺癌患者骨转移的危险因素分析
Am J Transl Res. 2022 Sep 15;14(9):6696-6702. eCollection 2022.
6
Clinical risk factors of carbohydrate antigen-125, cytokeratin fragment 19, and neuron-specific enolase in liver metastases from elderly lung cancer patients.老年肺癌患者肝转移中糖类抗原125、细胞角蛋白片段19和神经元特异性烯醇化酶的临床危险因素
Front Genet. 2022 Sep 29;13:1013253. doi: 10.3389/fgene.2022.1013253. eCollection 2022.
7
Overview of Ca signaling in lung cancer progression and metastatic lung cancer with bone metastasis.肺癌进展及伴有骨转移的转移性肺癌中钙信号传导概述。
Explor Target Antitumor Ther. 2021;2(3):249-265. doi: 10.37349/etat.2021.00045. Epub 2021 Jun 28.
8
Roles of the RANKL-RANK Axis in Immunity-Implications for Pathogenesis and Treatment of Bone Metastasis.RANKL-RANK轴在免疫中的作用——对骨转移发病机制和治疗的启示
Front Immunol. 2022 Mar 21;13:824117. doi: 10.3389/fimmu.2022.824117. eCollection 2022.
9
Automatic identification of suspicious bone metastatic lesions in bone scintigraphy using convolutional neural network.利用卷积神经网络自动识别骨闪烁扫描中的可疑骨转移病灶。
BMC Med Imaging. 2021 Sep 4;21(1):131. doi: 10.1186/s12880-021-00662-9.
10
Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China.肺癌同步骨转移：来自中国天津单中心 15716 例患者的回顾性研究。
BMC Cancer. 2021 May 26;21(1):613. doi: 10.1186/s12885-021-08379-2.
本文引用的文献
1
miR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways.miR-335 通过 IGF-IR 和 RANKL 通路抑制小细胞肺癌骨转移。
Mol Cancer Res. 2014 Jan;12(1):101-10. doi: 10.1158/1541-7786.MCR-13-0136. Epub 2013 Aug 21.
2
Clinical significance of disseminated tumour cells in non-small cell lung cancer.非小细胞肺癌中播散肿瘤细胞的临床意义。
Br J Cancer. 2013 Sep 3;109(5):1264-70. doi: 10.1038/bjc.2013.450. Epub 2013 Aug 13.
3
4
Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer.Notch3 过表达与人类非小细胞肺癌的不良预后相关。
Med Oncol. 2013;30(2):595. doi: 10.1007/s12032-013-0595-7. Epub 2013 May 7.
5
MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein.微小RNA-33a通过靶向甲状旁腺激素相关蛋白发挥肺癌骨转移抑制因子的作用。
Biochim Biophys Acta. 2013 Jun;1830(6):3756-66. doi: 10.1016/j.bbagen.2013.02.022. Epub 2013 Mar 1.
6
Targeting receptor activator of nuclear factor-kappa B as a new therapy for bone metastasis in non-small cell lung cancer.以核因子-κB 受体激活剂为靶点治疗非小细胞肺癌骨转移。
Curr Opin Oncol. 2013 Mar;25(2):137-44. doi: 10.1097/CCO.0b013e32835d720b.
7
Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.髓系来源的抑制细胞作为新型破骨细胞前体，增强乳腺癌骨丢失。
Cancer Res. 2013 Jan 15;73(2):672-82. doi: 10.1158/0008-5472.CAN-12-2202. Epub 2012 Dec 14.
8
Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis.缺氧诱导因子介导的肿瘤-间质细胞相互作用促进血管生成、淋巴管生成和转移。
Oncogene. 2013 Aug 29;32(35):4057-63. doi: 10.1038/onc.2012.578. Epub 2012 Dec 10.
9
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.在随机 3 期研究中，与唑来膦酸相比，地舒单抗治疗肺癌和骨转移患者的总生存期得到改善：亚组分析。
J Thorac Oncol. 2012 Dec;7(12):1823-1829. doi: 10.1097/JTO.0b013e31826aec2b.
10
Coordinated regulation of myeloid cells by tumours.肿瘤对髓系细胞的协调调控。
Nat Rev Immunol. 2012 Mar 22;12(4):253-68. doi: 10.1038/nri3175.
Zotero 插件